Wygant Jonathan 4

What Happened

• Jonathan Wygant, Vice President and Chief Accounting Officer of Veracyte (VCYT), exercised 24,000 stock options (fully vested) by paying a $24.80 strike ($595,200) and sold 24,000 shares in the open market at a weighted average price of $45.40, generating gross proceeds of about $1,089,624 on May 22, 2026. The filing also reports a derivative disposal of 24,000 shares at $0.00 tied to the exercise (see footnote).

Key Details

• Transaction date: May 22, 2026.
• Exercise: 24,000 shares at $24.80 per share (cost $595,200). Footnote F2: option fully vested.
• Sale: 24,000 shares sold at a weighted average price of $45.40 (gross proceeds ~$1,089,624). Footnote F1: actual sale prices ranged $45.07–$45.69; weighted average reported.
• Additional line: 24,000-share derivative disposal at $0.00 reported (part of the exercise/settlement mechanics).
• Shares owned after the transaction: not specified in the filing excerpt.
• Timeliness: Filing dated May 27, 2026 for a May 22 transaction (filed five days later), which appears to be later than the usual Form 4 deadline of two business days.

Context

• This was an option exercise followed by an immediate sale of the same shares (commonly a cashless exercise or sale-to-cover), so the net economic effect is a realized sale rather than a new long-term purchase. Sales by executives are often routine (to cover taxes or exercise costs); the filing documents the mechanics (exercise, sale, and a $0.00 derivative disposition) but does not explain the insider’s motivation.